These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19053968)

  • 1. Prospective comparison of course of disability in antipsychotic-treated and untreated schizophrenia patients.
    Thirthalli J; Venkatesh BK; Kishorekumar KV; Arunachala U; Venkatasubramanian G; Subbakrishna DK; Gangadhar BN
    Acta Psychiatr Scand; 2009 Mar; 119(3):209-17. PubMed ID: 19053968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of untreated psychosis and it's effect on the functional outcome in schizophrenia - preliminary results.
    Sarotar BN; Pesek MB; Agius M; Pregelj P; Kocmur M
    Psychiatr Danub; 2008 Jun; 20(2):179-83. PubMed ID: 18587288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics.
    Wunderink L; Nienhuis FJ; Sytema S; Wiersma D
    Schizophr Bull; 2007 May; 33(3):792-6. PubMed ID: 16894026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multifollow-up study.
    Harrow M; Jobe TH
    J Nerv Ment Dis; 2007 May; 195(5):406-14. PubMed ID: 17502806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
    Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
    Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled, mirror-image study of second-generation antipsychotics in the treatment of schizophrenia.
    Taylor D; Hayhurst K; Kerwin R
    Int Clin Psychopharmacol; 2007 May; 22(3):133-6. PubMed ID: 17414738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia.
    Hofer A; Rettenbacher MA; Edlinger M; Kemmler G; Widschwendter CG; Fleischhacker WW
    Acta Psychiatr Scand; 2007 Nov; 116(5):354-61. PubMed ID: 17868428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose of multiple antipsychotics and cognitive function in schizophrenia: the effect of dose-reduction.
    Kawai N; Yamakawa Y; Baba A; Nemoto K; Tachikawa H; Hori T; Asada T; Iidaka T
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1009-14. PubMed ID: 16644082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of untreated psychosis and it's effect on the symptomatic recovery in schizophrenia - preliminary results.
    Novak Sarotar B; Pesek MB; Agius M; Kocmur M
    Neuro Endocrinol Lett; 2008 Dec; 29(6):990-4. PubMed ID: 19112411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yoga therapy as an add-on treatment in the management of patients with schizophrenia--a randomized controlled trial.
    Duraiswamy G; Thirthalli J; Nagendra HR; Gangadhar BN
    Acta Psychiatr Scand; 2007 Sep; 116(3):226-32. PubMed ID: 17655565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of 3-year psychiatric daycare treatment in patients with schizophrenia.
    Inadomi H; Tanaka G; Watanabe S; Nagatomi Y; Mitarai K; Ohsawa R; Kusumeki K; Shimatani T; Hatanaka K; Hiroike T; Teramoto K; Utsunomiya H; Etoh R; Ohta Y
    Psychiatry Clin Neurosci; 2005 Jun; 59(3):246-52. PubMed ID: 15896216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disability in schizophrenia: clinical correlates and prediction over 1-year follow-up.
    Alptekin K; Erkoç S; Göğüş AK; Kültür S; Mete L; Uçok A; Yazici KM
    Psychiatry Res; 2005 Jun; 135(2):103-11. PubMed ID: 15923043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reliability and validity of the Test of Adaptive Behavior in Schizophrenia (TABS).
    Velligan DI; Diamond P; Glahn DC; Ritch J; Maples N; Castillo D; Miller AL
    Psychiatry Res; 2007 May; 151(1-2):55-66. PubMed ID: 17379319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Mannheim long-term study of schizophrenia. Initial results of follow-up of the illness over 14 years after initial inpatient treatment].
    an der Heiden W; Krumm B; Müller S; Weber I; Biehl H; Schäfer M
    Nervenarzt; 1995 Nov; 66(11):820-7. PubMed ID: 8532098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients.
    Lee HY; Kim DJ; Lee HJ; Choi JE; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):276-80. PubMed ID: 19059448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prospective evaluation of the early course of schizophrenia in men and women after a first psychiatric hospitalization].
    Jaracz K; Górna K; Kiejda J; Rybakowski J
    Psychiatr Pol; 2008; 42(1):33-46. PubMed ID: 18567402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of antipsychotic treatments on the motivation to eat: preliminary results in 153 schizophrenic patients.
    Sentissi O; Viala A; Bourdel MC; Kaminski F; Bellisle F; Olié JP; Poirier MF
    Int Clin Psychopharmacol; 2009 Sep; 24(5):257-64. PubMed ID: 19606055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of longitudinal changes in schizophrenia: the role of processing speed.
    Sánchez P; Ojeda N; Peña J; Elizagárate E; Yoller AB; Gutiérrez M; Ezcurra J
    J Clin Psychiatry; 2009 Jun; 70(6):888-96. PubMed ID: 19422757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.
    Rossi A; Bagalà A; Del Curatolo V; Scapati F; Bernareggi MM; Giustra MG;
    Hum Psychopharmacol; 2009 Oct; 24(7):574-83. PubMed ID: 19790173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.